ID
32734
Beschrijving
Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation
Trefwoorden
Versies (1)
- 13/11/2018 13/11/2018 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
13 de novembro de 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059
IP Compliance
- StudyEvent: ODM
Beschrijving
IP Compliance Dispensed
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
- UMLS CUI-3
- C1880359
Beschrijving
Experimental Drug, Dispense, Date in time
Datatype
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C0011008
Beschrijving
Experimental Drug, Blister Pack, First, Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205435
- UMLS CUI [1,4]
- C0237753
Beschrijving
Experimental Drug, Dispense, Blister Pack, First, Count of entities
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205435
- UMLS CUI [1,5]
- C0449788
Beschrijving
Experimental Drug, Blister Pack, Second, Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205436
- UMLS CUI [1,4]
- C0237753
Beschrijving
Experimental Drug, Dispense, Blister Pack, Second, Count of entities
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205436
- UMLS CUI [1,5]
- C0449788
Similar models
IP Compliance
- StudyEvent: ODM
C1321605 (UMLS CUI-2)
C0332156 (UMLS CUI-3)
C0332156 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1290952 (UMLS CUI [1,2])
C1290952 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1321605 (UMLS CUI-2)
C1880359 (UMLS CUI-3)
C1880359 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
Geen commentaren